IDEAS home Printed from https://ideas.repec.org/a/wly/hlthec/v18y2009i4p487-494.html

The valuation of prenatal life in economic evaluations of perinatal interventions

Author

Listed:
  • Judit Simon
  • Stavros Petrou
  • Alastair Gray

Abstract

Perinatal interventions delivered during the prenatal period have the potential to directly impact prenatal life. The decision on when to begin ‘counting’ the life of an infant in the calculus has received little attention in previous economic evaluations of perinatal interventions. We illustrate, using data from a recent trial‐based economic evaluation of magnesium sulphate given to women with pre‐eclampsia to prevent eclampsia, how different definitions of when human life commences can have a significant impact upon cost‐effectiveness estimates based on composite outcome measures such as life years or quality‐adjusted life years gained or disability‐adjusted life years averted. Further, we suggest ways in which methods in this area can be improved. Copyright © 2008 John Wiley & Sons, Ltd.

Suggested Citation

  • Judit Simon & Stavros Petrou & Alastair Gray, 2009. "The valuation of prenatal life in economic evaluations of perinatal interventions," Health Economics, John Wiley & Sons, Ltd., vol. 18(4), pages 487-494, April.
    • Handle: RePEc:wly:hlthec:v:18:y:2009:i:4:p:487-494
    DOI: 10.1002/hec.1375
    as

    Download full text from publisher

    File URL: https://doi.org/10.1002/hec.1375
    Download Restriction: no
    File URL: https://libkey.io/10.1002/hec.1375?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Drummond, Michael F. & Sculpher, Mark J. & Torrance, George W. & O'Brien, Bernie J. & Stoddart, Greg L., 2005. "Methods for the Economic Evaluation of Health Care Programmes," OUP Catalogue, Oxford University Press, edition 3, number 9780198529453.
    2. Julia Fox-Rushby, 2002. "Disability Adjusted Life Years (DALYs) for Decision-Making?," Monograph 000474, Office of Health Economics.
    3. Broome, John, 2006. "Weighing Lives," OUP Catalogue, Oxford University Press, number 9780199297702.
    4. World Bank, 2003. "World Development Indicators 2003," World Bank Publications - Books, The World Bank Group, number 13920, April.
    5. Radhakrishnan, Muralikrishnan & van Gool, Kees & Hall, Jane & Delatycki, Martin & Massie, John, 2008. "Economic evaluation of cystic fibrosis screening: A review of the literature," Health Policy, Elsevier, vol. 85(2), pages 133-147, February.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Samuel Shillcutt & Damian Walker & Catherine Goodman & Anne Mills, 2009. "Cost Effectiveness in Low- and Middle-Income Countries," PharmacoEconomics, Springer, vol. 27(11), pages 903-917, November.
    2. Jeremy D. Goldhaber-Fiebert & Margaret L. Brandeau, 2015. "Evaluating Cost-effectiveness of Interventions That Affect Fertility and Childbearing," Medical Decision Making, , vol. 35(7), pages 818-846, October.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Mara Airoldi & Alec Morton, 2009. "Adjusting life for quality or disability: stylistic difference or substantial dispute?," Health Economics, John Wiley & Sons, Ltd., vol. 18(11), pages 1237-1247, November.
    2. Ulla Kou Griffiths & Rosa Legood & Catherine Pitt, 2016. "Comparison of Economic Evaluation Methods Across Low‐income, Middle‐income and High‐income Countries: What are the Differences and Why?," Health Economics, John Wiley & Sons, Ltd., vol. 25(S1), pages 29-41, February.
    3. Chaminade, Cristina & Vang, Jan, 2005. "Innovation Policies for Small and Medium Size Enterprises in Asia: An Innovation Systems Perspective," Papers in Innovation Studies 2005/6, Lund University, CIRCLE - Centre for Innovation Research.
    4. Paal Joranger & Arild Nesbakken & Halfdan Sorbye & Geir Hoff & Arne Oshaug & Eline Aas, 2020. "Survival and costs of colorectal cancer treatment and effects of changing treatment strategies: a model approach," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 21(3), pages 321-334, April.
    5. Antonio Andres & Carlyn Ramlogan-Dobson, 2011. "Is Corruption Really Bad for Inequality? Evidence from Latin America," Journal of Development Studies, Taylor & Francis Journals, vol. 47(7), pages 959-976.
    6. Saha, Sanjib & Gerdtham, Ulf-G. & Toresson, Håkan & Minthon, Lennart & Jarl, Johan, 2018. "Economic Evaluation of Interventions for Screening of Dementia," Working Papers 2018:20, Lund University, Department of Economics.
    7. Mark Oppe & Daniela Ortín-Sulbarán & Carlos Vila Silván & Anabel Estévez-Carrillo & Juan M. Ramos-Goñi, 2021. "Cost-effectiveness of adding Sativex® spray to spasticity care in Belgium: using bootstrapping instead of Monte Carlo simulation for probabilistic sensitivity analyses," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 22(5), pages 711-721, July.
    8. Amita Batra, 2006. "India's Global Trade Potential: The Gravity Model Approach," Global Economic Review, Taylor & Francis Journals, vol. 35(3), pages 327-361.
    9. Laurence M. Djatche & Stefan Varga & Robert D. Lieberthal, 2018. "Cost-Effectiveness of Aspirin Adherence for Secondary Prevention of Cardiovascular Events," PharmacoEconomics - Open, Springer, vol. 2(4), pages 371-380, December.
    10. Paldam, Martin, 2004. "Introduction to the 2003 European Public Choice Society plenary lectures: The Nordic welfare state--success under stress," European Journal of Political Economy, Elsevier, vol. 20(3), pages 739-742, September.
    11. Ties Hoomans & Johan Severens & Nicole Roer & Gepke Delwel, 2012. "Methodological Quality of Economic Evaluations of New Pharmaceuticals in the Netherlands," PharmacoEconomics, Springer, vol. 30(3), pages 219-227, March.
    12. Masciandaro, D. & Nieto, M. & Prast, H.M., 2007. "Financial Governance of Banking Supervision," Other publications TiSEM 65d7ff26-dca3-4da3-86ff-6, Tilburg University, School of Economics and Management.
    13. Lidia García-Pérez & Ignacio Abásolo-Alessón & Miguel Ángel Negrín-Hernández, 2026. "Exploring the Generalizability of Foreign Cost-Effectiveness Analysis to Spain Using Data From a Scoping Review of Multinational Studies," PharmacoEconomics, Springer, vol. 44(1), pages 43-60, January.
    14. Abdallah Shehata & Prof. Lobna Abdelatif, 2006. "Fiscal Sustainability and the Role of the State: a New Analytical Framework," EcoMod2006 272100082, EcoMod.
    15. Khan, Mohammed Tajuddin & Kishore, Avinash & Joshi, Pramod K., 2016. "Gender dimensions on farmers’ preferences for direct-seeded rice with drum seeder in India," IFPRI discussion papers 1550, International Food Policy Research Institute (IFPRI).
    16. Daphne C. Voormolen & Judith A. M. Bom & Esther W. de Bekker-Grob & Werner B. F. Brouwer & Job van Exel, 2024. "Development and Content Validation of the 10-item Well-being Instrument (WiX) for use in Economic Evaluation Studies," Applied Research in Quality of Life, Springer;International Society for Quality-of-Life Studies, vol. 19(2), pages 381-413, April.
    17. Noémi Kreif & Richard Grieve & M. Zia Sadique, 2013. "Statistical Methods For Cost‐Effectiveness Analyses That Use Observational Data: A Critical Appraisal Tool And Review Of Current Practice," Health Economics, John Wiley & Sons, Ltd., vol. 22(4), pages 486-500, April.
    18. Md. Nazmul Hasan & Rafia Nishat Toma & Abdullah-Al Nahid & M M Manjurul Islam & Jong-Myon Kim, 2019. "Electricity Theft Detection in Smart Grid Systems: A CNN-LSTM Based Approach," Energies, MDPI, vol. 12(17), pages 1-18, August.
    19. Marie-Louise Leroux & Pierre Pestieau & Grégory Ponthière, 2015. "Longévité différentielle et redistribution : enjeux théoriques et empiriques," L'Actualité Economique, Société Canadienne de Science Economique, vol. 91(4), pages 465-497.
    20. Barbara Graaff & Lei Si & Amanda L. Neil & Kwang Chien Yee & Kristy Sanderson & Lyle C. Gurrin & Andrew J. Palmer, 2017. "Population Screening for Hereditary Haemochromatosis in Australia: Construction and Validation of a State-Transition Cost-Effectiveness Model," PharmacoEconomics - Open, Springer, vol. 1(1), pages 37-51, March.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:wly:hlthec:v:18:y:2009:i:4:p:487-494. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Wiley Content Delivery (email available below). General contact details of provider: http://www3.interscience.wiley.com/cgi-bin/jhome/5749 .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.